Adverum Biotechnologies
ADVM
ADVM
110 hedge funds and large institutions have $155M invested in Adverum Biotechnologies in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
-8
Holders Change %
-6.78%
% of All Funds
1.93%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
34
Reduced
39
Closed
20
Calls
$5.78M
Puts
$2.05M
Net Calls
+$3.73M
Net Calls Change
+$3.74M
Top Buyers
| 1 |
HF
1
HRT Financial
New York
|
$1.84M |
| 2 |
2
Two Sigma Advisers
New York
|
$3.83M |
| 3 |
3
Millennium Management
New York
|
$1.68M |
| 4 |
KPF
4
K2 Principal Fund
Toronto,
Ontario, Canada
|
$3.59M |
| 5 |
5
Morgan Stanley
New York
|
$3.16M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$4.44M |
| 2 |
DM
2
Deerfield Management
New York
|
$0 |
| 3 |
3
Citigroup
New York
|
$151K |
| 4 |
4
BlackRock
New York
|
$16.1M |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$1.62M |
